KLRS
Kalaris Therapeutics, Inc.Company with tickers: KLRS
CIK
1754068
CUSIP
482929106
Shares Outstanding
23,792,278
13F Activity (30d)
42 filings
41 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-03 | Dybbs Michael |
Director | Award | 9,000 |
| 2026-06-03 | AKKARAJU SRINIVAS |
Director, 10% Owner | Award | 9,000 |
| 2026-06-03 | Jovan-Embiricos Morana |
10% Owner | Award | 9,000 |
| 2026-06-03 | Hallal David |
Director, Chief Executive Officer | Award | 9,000 |
| 2026-06-03 | ADAMIS ANTHONY P |
Director | Award | 9,000 |
| 2026-06-03 | PATTERSON LEONE D |
EVP, Chief Bus & Fin Officer | Award | 9,000 |
| 2026-06-03 | Ferrara Napoleone |
Director | Award | 9,000 |
| 2026-05-20 | AKKARAJU SRINIVAS |
Director, 10% Owner | Other | 66,906 |
| 2026-05-20 | AKKARAJU SRINIVAS |
Director, 10% Owner | Other | 4,471 |
| 2026-05-20 | AKKARAJU SRINIVAS |
Director, 10% Owner | Buy | 244,300 |
| 2026-05-20 | AKKARAJU SRINIVAS |
Director, 10% Owner | Other | 14,937 |
| 2026-03-20 | Hagen Brett R |
Chief Accounting Officer | Sell | 1,915 |
| 2026-03-19 | Feinsod Matthew |
Chief Medical Officer | Award | 135,000 |
| 2026-03-19 | Gall Matthew |
Chief Financial Officer | Award | 95,000 |
| 2026-03-19 | Hagen Brett R |
Chief Accounting Officer | Award | 60,800 |
| 2026-03-19 | Oxtoby Andrew |
Director, See Remarks | Award | 222,000 |
| 2025-12-22 | AKKARAJU SRINIVAS |
Director, 10% Owner | Other | 11,448,081 |
| 2025-12-22 | AKKARAJU SRINIVAS |
Director, 10% Owner | Award | 1,500,000 |
| 2025-12-18 | AKKARAJU SRINIVAS |
Director, 10% Owner | Buy | 479,847 |
| 2025-12-18 | AKKARAJU SRINIVAS |
Director, 10% Owner | Other | 10,968,234 |
| 2025-11-03 | Gall Matthew |
Chief Financial Officer | Award | 235,000 |
| 2025-11-03 | Gall Matthew |
Chief Financial Officer | Other | 0 |
| 2025-04-10 | Dybbs Michael |
Director | Award | 18,000 |
| 2025-04-10 | Feinsod Matthew |
Chief Medical Officer | Award | 101,000 |
| 2025-04-10 | PATTERSON LEONE D |
EVP, Chief Bus & Fin Officer | Award | 18,000 |
| 2025-04-10 | PATEL SAMIR CHANDRAKANT |
Director | Award | 18,000 |
| 2025-04-10 | Oxtoby Andrew |
Director, See Remarks | Award | 287,000 |
| 2025-04-10 | ADAMIS ANTHONY P |
Director | Award | 18,000 |
| 2025-04-10 | Feinsod Matthew |
Chief Medical Officer | Award | 70,551 |
| 2025-04-10 | AKKARAJU SRINIVAS |
Director, 10% Owner | Award | 18,000 |
| 2025-04-10 | Hagen Brett R |
Chief Accounting Officer | Award | 50,262 |
| 2025-04-10 | Ferrara Napoleone |
Director | Award | 18,000 |
| 2025-04-10 | Hallal David |
Director, Chief Executive Officer | Award | 18,000 |
| 2025-04-10 | Jovan-Embiricos Morana |
10% Owner | Award | 18,000 |
| 2025-04-03 | PATTERSON LEONE D |
EVP, Chief Bus & Fin Officer | Other | 0 |
| 2025-03-26 | Hagen Brett R |
Chief Accounting Officer | Sell | 907 |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT |
Director | Award | 105,913 |
| 2025-03-18 | AKKARAJU SRINIVAS |
Director, 10% Owner | Other | 0 |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT |
Director | Award | 100,800 |
| 2025-03-18 | ADAMIS ANTHONY P |
Director | Award | 12,989 |
| 2025-03-18 | Dybbs Michael |
Director | Other | 0 |
| 2025-03-18 | Oxtoby Andrew |
Director, See Remarks | Award | 476,611 |
| 2025-03-18 | Oxtoby Andrew |
Director, See Remarks | Other | 0 |
| 2025-03-18 | Feinsod Matthew |
Chief Medical Officer | Other | 0 |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT |
Director | Award | 252,000 |
| 2025-03-18 | ADAMIS ANTHONY P |
Director | Award | 19,484 |
| 2025-03-18 | Feinsod Matthew |
Chief Medical Officer | Award | 28,224 |
| 2025-03-18 | Feinsod Matthew |
Chief Medical Officer | Award | 4,030 |
| 2025-03-18 | AKKARAJU SRINIVAS |
Director, 10% Owner | Award | 11,444,503 |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT |
Director | Other | 0 |
Showing 1–50 of 767 transactions